121 related articles for article (PubMed ID: 38661110)
1. Maternal awareness, acceptability and willingness towards respiratory syncytial virus (RSV) vaccination during pregnancy in Ireland.
McCormack S; Thompson C; Nolan M; Imcha M; Dee A; Saunders J; Philip RK
Immun Inflamm Dis; 2024 Apr; 12(4):e1257. PubMed ID: 38661110
[TBL] [Abstract][Full Text] [Related]
2. A latent class analysis of factors influencing preferences for infant respiratory syncytial virus (RSV) preventives among pregnant people in the United States.
Maculaitis MC; Hauber B; Beusterien KM; Will O; Kopenhafer L; Law AW; Vietri JT; Cappelleri JC; Coulter JR; Pugh S; Shea KM
Hum Vaccin Immunother; 2024 Dec; 20(1):2358566. PubMed ID: 38847198
[TBL] [Abstract][Full Text] [Related]
3. Respiratory Syncytial Virus Maternal Vaccination in Infants below 6 Months of Age: Meta-Analysis of Safety, Immunogenicity, and Efficacy.
Mapindra MP; Mahindra MP; McNamara P; Semple MG; Clark H; Madsen J
Neonatology; 2024; 121(3):271-282. PubMed ID: 38286126
[TBL] [Abstract][Full Text] [Related]
4. Predictors of maternal pertussis vaccination acceptance among pregnant women in Norway.
Hansen BT; Winje BA; Stålcrantz J; Greve-Isdahl M
Hum Vaccin Immunother; 2024 Dec; 20(1):2361499. PubMed ID: 38847213
[TBL] [Abstract][Full Text] [Related]
5. Safety and Immunogenicity of a Respiratory Syncytial Virus Fusion (F) Protein Nanoparticle Vaccine in Healthy Third-Trimester Pregnant Women and Their Infants.
Muňoz FM; Swamy GK; Hickman SP; Agrawal S; Piedra PA; Glenn GM; Patel N; August AM; Cho I; Fries L
J Infect Dis; 2019 Oct; 220(11):1802-1815. PubMed ID: 31402384
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 vaccine acceptance among pregnant women: a multicentre cross-sectional survey in Port Harcourt, Nigeria.
Omunakwe HE; Okuku M; Amadi SC; Dan-Jumbo A
Pan Afr Med J; 2024; 47():72. PubMed ID: 38708131
[TBL] [Abstract][Full Text] [Related]
7. Women's acceptance of two strategies for preventing respiratory syncytial virus infant bronchiolitis: maternal immunization or monoclonal antibodies for newborns.
Roblin A; Lachâtre M; Charlier C; Launay O; Tsatsaris V; Anselem O
Clin Microbiol Infect; 2024 Jul; 30(7):958-960. PubMed ID: 38492738
[No Abstract] [Full Text] [Related]
8. Knowledge, attitudes, and perceptions of influenza vaccine among pregnant women in Minhang District, Shanghai.
Lu Y; Fu X; Xu L; Lu J
Hum Vaccin Immunother; 2024 Dec; 20(1):2368944. PubMed ID: 38932738
[TBL] [Abstract][Full Text] [Related]
9. Respiratory syncytial virus seasonality and its implications on prevention strategies.
Janet S; Broad J; Snape MD
Hum Vaccin Immunother; 2018 Jan; 14(1):234-244. PubMed ID: 29194014
[TBL] [Abstract][Full Text] [Related]
10. Parental knowledge on the respiratory syncytial virus before the nirsevimab immunization program: Attitudes toward immunization in an autonomous community of Spain.
Zornoza Moreno M; Pérez Martín JJ; Moreno MCG; Abellán MPR
Hum Vaccin Immunother; 2024 Dec; 20(1):2357439. PubMed ID: 38857859
[TBL] [Abstract][Full Text] [Related]
11. Nonadjuvanted Bivalent Respiratory Syncytial Virus Vaccination and Perinatal Outcomes.
Son M; Riley LE; Staniczenko AP; Cron J; Yen S; Thomas C; Sholle E; Osborne LM; Lipkind HS
JAMA Netw Open; 2024 Jul; 7(7):e2419268. PubMed ID: 38976271
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 Vaccine Acceptance in Pregnancy.
Odedokun T; Marquez R; Thakkar M; Dinglas C; Kady DE
Am J Perinatol; 2024 May; 41(S 01):e617-e622. PubMed ID: 36261065
[TBL] [Abstract][Full Text] [Related]
13. The respiratory syncytial virus vaccines are here: Implications for solid organ transplantation.
Trubin P; Azar MM; Kotton CN
Am J Transplant; 2024 Jun; 24(6):897-904. PubMed ID: 38341028
[TBL] [Abstract][Full Text] [Related]
14. Exploring parental perspectives: Maternal RSV vaccination versus infant RSV monoclonal antibody.
Treston B; Geoghegan S
Hum Vaccin Immunother; 2024 Dec; 20(1):2341505. PubMed ID: 38723786
[TBL] [Abstract][Full Text] [Related]
15. The relationship between vaccine hesitancy and health literacy in pregnant women: a cross-sectional study.
Çetin K; Sögüt SC
BMC Womens Health; 2024 Jun; 24(1):361. PubMed ID: 38907226
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness Analysis of Maternal Immunization with RSVpreF Vaccine for the Prevention of Respiratory Syncytial Virus Among Infants in Spain.
Álvarez Aldean J; Rivero Calle I; Rodríguez Fernández R; Aceituno Mata S; Bellmunt A; Prades M; Law AW; López-Ibáñez de Aldecoa A; Méndez C; García Somoza ML; Soto J; Lozano V
Infect Dis Ther; 2024 Jun; 13(6):1315-1331. PubMed ID: 38733493
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 vaccine acceptance and associated factors among pregnant and lactating women attending maternity care clinics in refugee camps in Jordan.
Dalky A; Quran TO; Abuhammad S; Al-Faraj HM; Bani Hani S; ALBashtawy M; Abu Khader IR; Jallad M; Salameh B
PLoS One; 2024; 19(6):e0305314. PubMed ID: 38861556
[TBL] [Abstract][Full Text] [Related]
18. Pregnant women and older adults in England and Scotland to be offered RSV vaccination.
Mahase E
BMJ; 2024 Jun; 385():q1436. PubMed ID: 38936955
[No Abstract] [Full Text] [Related]
19. Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper.
Redondo E; Rivero-Calle I; Mascarós E; Ocaña D; Jimeno I; Gil Á; Linares M; Onieva-García MÁ; González-Romo F; Yuste J; Martinón-Torres F
Arch Bronconeumol; 2024 Mar; 60(3):161-170. PubMed ID: 38311509
[TBL] [Abstract][Full Text] [Related]
20. Perinatal Outcomes After RSV Vaccination During Pregnancy-Addressing Emerging Concerns.
Regan AK
JAMA Netw Open; 2024 Jul; 7(7):e2419229. PubMed ID: 38976273
[No Abstract] [Full Text] [Related]
[Next] [New Search]
